WallStreetZenWallStreetZen

NASDAQ: CAPR
Capricor Therapeutics Inc Stock Ownership - Who owns Capricor Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Capricor Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Anthony BergmannCHIEF FINANCIAL OFFICER2025-03-032,500$1.39
$3.47kBuy
George W. Dunbar Jr.Director2025-03-03750$1.39
$1.04kBuy
Frank LitvackDirector2025-03-0325,000$1.39
$34.75kBuy
Frank LitvackDirector2025-03-032,543$13.67
$34.76kSell
Linda MarbanCHIEF EXECUTIVE OFFICER2025-03-0325,000$1.39
$34.75kBuy
Earl M. Collier Jr.Director2025-02-27750$1.39
$1.04kBuy

1 of 1

CAPR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CAPR insiders and whales buy or sell their stock.

CAPR Shareholders

What type of owners hold Capricor Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Nippon Shinyaku Co Ltd15.51%7,090,351$184.49MInsider
Fountainhead Capital Partners Ltd12.14%5,551,000$144.44MInsider
Sinai Medical Center Cedars8.86%4,049,959$105.38MInsider
Eduardo Marban7.24%3,307,863$86.07MInsider
John Edward A. St6.78%3,101,574$80.70MInsider
Louis J. Grasmick6.43%2,937,729$76.44MInsider
Peter M. Kash6.39%2,920,446$75.99MInsider
Blackrock Inc6.28%2,870,172$74.68MInstitution
Wexford Capital LP5.70%2,606,778$67.83MInsider
Vanguard Group Inc4.83%2,206,719$57.42MInstitution

1 of 3

CAPR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CAPR27.03%72.97%Net Buying
XERS58.40%14.81%Net SellingNet Buying
ALMS74.71%25.12%Net BuyingNet Buying
XNCR72.07%27.93%Net Selling
TYRA62.03%37.97%Net BuyingNet Selling
View Top Biotech Stocks

Capricor Therapeutics Stock Ownership FAQ

Who owns Capricor Therapeutics?

Capricor Therapeutics (NASDAQ: CAPR) is owned by 31.56% institutional shareholders, 85.18% Capricor Therapeutics insiders, and 0.00% retail investors. Nippon Shinyaku Co Ltd is the largest individual Capricor Therapeutics shareholder, owning 7.09M shares representing 15.51% of the company. Nippon Shinyaku Co Ltd's Capricor Therapeutics shares are currently valued at $184.49M.

If you're new to stock investing, here's how to buy Capricor Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.